Mexico Regenerative Medicine Market Size & Outlook

The regenerative medicine market in Mexico is expected to reach a projected revenue of US$ 266.4 million by 2030. A compound annual growth rate of 8.1% is expected of Mexico regenerative medicine market from 2025 to 2030.
Revenue, 2024 (US$M)
$163.5
Forecast, 2030 (US$M)
$266.4
CAGR, 2025 - 2030
8.1%
Report Coverage
Mexico

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico regenerative medicine market, 2018-2030 (US$M)

Mexico regenerative medicine market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico regenerative medicine market highlights

  • The Mexico regenerative medicine market generated a revenue of USD 163.5 million in 2024 and is expected to reach USD 266.4 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 8.1% from 2025 to 2030.
  • In terms of segment, therapeutics was the largest revenue generating product in 2024.
  • Banks is the most lucrative product segment registering the fastest growth during the forecast period.

Regenerative medicine market data book summary

Market revenue in 2024USD 163.5 million
Market revenue in 2030USD 266.4 million
Growth rate8.1% (CAGR from 2025 to 2030)
Largest segmentTherapeutics
Fastest growing segmentBanks
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTherapeutics, Tools, Banks, Services
Key market players worldwideAstraZeneca PLC, Roche Holding AG, Integra Lifesciences Holdings Corp, Astellas Pharma Inc, Cook Group, Bayer AG, Pfizer Inc, Merck KGaA, Abbott Laboratories, Vericel Corp, Novartis AG ADR, GlaxoSmithKline

Other key industry trends

  • In terms of revenue, Mexico accounted for 0.5% of the global regenerative medicine market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. regenerative medicine market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 49,319.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Regenerative Medicine Market Companies

Name Profile # Employees HQ Website
Cook Group View profile 10001+ Bloomington, Indiana, United States, North America http://www.cookgroup.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Astellas Pharma Inc View profile 14484 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 http://www.astellas.com
Vericel Corp View profile 314 64 Sidney Street, Cambridge, MA, United States, 02139 https://www.vcel.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Integra Lifesciences Holdings Corp View profile 3946 1100 Campus Road, Princeton, NJ, United States, 08540 https://www.integralife.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Mexico regenerative medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regenerative medicine market will help companies and investors design strategic landscapes.


Therapeutics was the largest segment with a revenue share of 85.08% in 2024. Horizon Databook has segmented the Mexico regenerative medicine market based on therapeutics, tools, banks, services covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Mexico regenerative medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico regenerative medicine market databook

  • Our clientele includes a mix of regenerative medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into Mexico regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico regenerative medicine market size, by product, 2018-2030 (US$M)

Mexico Regenerative Medicine Market Outlook Share, 2024 & 2030 (US$M)

Mexico regenerative medicine market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online